Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 2;11(11):CD013864.
doi: 10.1002/14651858.CD013864.pub2.

Antibiotics for hospital-acquired pneumonia in neonates and children

Steven Kwasi Korang  1 , Chiara Nava  2 , Sutharshini Punniyamoorthy Mohana  3 , Ulrikka Nygaard  4 , Janus C Jakobsen  1   5
Affiliations

Antibiotics for hospital-acquired pneumonia in neonates and children

Steven Kwasi Korang et al. Cochrane Database Syst Rev. .

Abstract

Background: Hospital-acquired pneumonia is one of the most common hospital-acquired infections in children worldwide. Most of our understanding of hospital-acquired pneumonia in children is derived from adult studies. To our knowledge, no systematic review with meta-analysis has assessed the benefits and harms of different antibiotic regimens in neonates and children with hospital-acquired pneumonia.

Objectives: To assess the beneficial and harmful effects of different antibiotic regimens for hospital-acquired pneumonia in neonates and children.

Search methods: We searched CENTRAL, MEDLINE, Embase, three other databases, and two trial registers to February 2021, together with reference checking, citation searching, and contact with study authors to identify additional studies.

Selection criteria: We included randomised clinical trials comparing one antibiotic regimen with any other antibiotic regimen for hospital-acquired pneumonia in neonates and children.

Data collection and analysis: Three review authors independently assessed studies for inclusion, extracted data, and assessed risk of bias. We assessed the certainty of the evidence using the GRADE approach. Our primary outcomes were all-cause mortality and serious adverse events; our secondary outcomes were health-related quality of life, pneumonia-related mortality, non-serious adverse events, and treatment failure. Our primary time point of interest was at maximum follow-up.

Main results: We included four randomised clinical trials (84 participants). We assessed all trials as having high risk of bias. We did not conduct any meta-analyses, as the included trials did not compare similar antibiotic regimens. Each of the four trials assessed a different comparison, as follows: cefepime versus ceftazidime; linezolid versus vancomycin; meropenem versus cefotaxime; and ceftobiprole versus cephalosporin. Only one trial reported our primary outcomes of all-cause mortality and serious adverse events. Three trials reported our secondary outcome of treatment failure. Two trials primarily included community-acquired pneumonia and hospitalised children with bacterial infections, hence the children with hospital-acquired pneumonia constituted subgroups of the total sample sizes. Where outcomes were reported, the certainty of the evidence was very low for each of the comparisons. We are unable to draw meaningful conclusions from the numerical results. None of the included trials assessed health-related quality of life, pneumonia-related mortality, or non-serious adverse events.

Authors' conclusions: The relative beneficial and harmful effects of different antibiotic regimens remain unclear due to the very low certainty of the available evidence. The current evidence is insufficient to support any antibiotic regimen being superior to another. Randomised clinical trials assessing different antibiotic regimens for hospital-acquired pneumonia in children and neonates are warranted.

PubMed Disclaimer

Conflict of interest statement

The performance of this review is free of any real or perceived bias introduced by receipt of any benefit in cash or kind, on any subsidy derived from any source that may have or be perceived to have an interest in the outcomes of the review.

Steven Kwasi Korang: has declared that they have no conflict of interest. Chiara Nava: has declared that they have no conflict of interest. Sutharshini Punniyamoorthy Mohana: has declared that they have no conflict of interest. Ulrikka Nygaard: has declared that they have no conflict of interest. Janus C Jakobsen: has declared that they have no conflict of interest.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
1.1
1.1. Analysis
Comparison 1: Cefepime compared with ceftazidime, Outcome 1: All‐cause mortality
1.2
1.2. Analysis
Comparison 1: Cefepime compared with ceftazidime, Outcome 2: Serious adverse events
1.3
1.3. Analysis
Comparison 1: Cefepime compared with ceftazidime, Outcome 3: Treatment failure
2.1
2.1. Analysis
Comparison 2: Linezolid compared with vancomycin, Outcome 1: Treatment failure
3.1
3.1. Analysis
Comparison 3: Meropenem compared with cefotaxime, Outcome 1: Treatment failure
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD013864

References

References to studies included in this review

Bosheva 2021 {published data only}
    1. Bosheva M, Gujabidze R, Károly É, Nemeth A, Saulay M, Smart JL, et al. A phase 3 randomized investigator-blinded trial comparing ceftobiprole with a standard-of-care cephalosporin, with or without vancomycin, for the treatment of pneumonia in pediatric patients. Pediatric Infectious Disease Journal 2021 Jun 1 [Epub ahead of print]. [DOI: 10.1097/INF.0000000000003077] - DOI - PMC - PubMed
Jantausch 2003 {published data only}
    1. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatric Infectious Disease Journal 2003;22(Suppl 9):158-63. - PubMed
    1. Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, et al. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatric Infectious Disease Journal 2003;22(Suppl 9):164-71. - PubMed
    1. Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatric Infectious Disease Journal 2003;22(8):677-86. - PubMed
    1. Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, et al. Hematologic effects of linezolid in young children. Pediatric Infectious Disease Journal 2003;22(Suppl 9):186-92. - PubMed
    1. Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, et al. Safety and tolerability of linezolid in children. Pediatric Infectious Disease Journal 2003;22(Suppl 9):193-200. - PubMed
Schuler 1995 {published data only}
    1. Schuler D. Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group. Journal of Antimicrobial Chemotherapy 1995;36(Suppl A):99-108. - PubMed
Shahid 2008 {published data only}
    1. Shahid SK. Efficacy and safety of cefepime in late-onset ventilator-associated pneumonia in infants: a pilot randomized and controlled study. Annals of Tropical Medicine and Parasitology 2008;102(1):63-71. - PubMed

References to studies excluded from this review

Agweyu 2015 {published data only}
    1. Agweyu A, Gathara D, Oliwa J, Muinga N, Edwards T, Allen E, et al. Oral amoxicillin versus benzyl penicillin for severe pneumonia among Kenyan children: a pragmatic randomized controlled noninferiority trial. Clinical Infectious Diseases 2015;60(8):1216-24. - PMC - PubMed
Amonova 2011 {published data only}
    1. Amonova DS, Ibadova DN. Clinical and bacteriological efficiency of two modes of ceftazidim and aminkacin dosing in patients with ventilator-associated pneumonia. Likars'ka Sprava 2011;1(2):110-7. - PubMed
Awad 2014 {published data only}
    1. Awad SS, Rodriguez AH, Chuang YC, Marjanek Z, Pareigis AJ, Reis G, et al. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. Clinical Infectious Diseases 2014;69(1):51-61. - PMC - PubMed
Barradas 1989 {published data only}
    1. Barradas P, Zamith M, Videira W, Cardosa T, Marques RA, Avila R. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime. Chemotherapy 1989;35(Suppl 2):33-40. - PubMed
Bassetti 1991 {published data only}
    1. Bassetti D, Cruciani M, Solbiati M, Rubini F, Gandola L, Valenti G, et al. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections. Chemotherapy 1991;37(5):371-5. - PubMed
Begue 1998 {published data only}
    1. Begue P, Astruc J, Francois P, Floret D. Comparison of ceftriaxone and cefotaxime in severe pediatric bacterial infection: a multicentric study [Evaluation de la ceftriaxone et du cefotaxime dans l'infection bacterienne severe en pediatrie: etude muticentrique]. Medecine et Maladies Infectieuses 1998;28(4):300-6.
Berman 2004 {published data only}
    1. Berman SJ, Fogarty CM, Fabian T, Melnick D, Lesky W. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial. Journal of Chemotherapy 2004;16(4):362-71. - PubMed
Bhavnani 2012 {published data only}
    1. Bhavnani SM, Rubino CM, Hammel JP, Forrest A, Dartois N, Cooper CA, et al. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline. Antimicrobial Agents and Chemotherapy 2012;56(2):1065-72. - PMC - PubMed
Chaudhary 2008 {published data only}
    1. Chaudhary M, Shrivastava SM, Varughese L, Sehgal R. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. Current Clinical Pharmacology 2008;3(2):118-22. - PubMed
Chuchalin 1997 {published data only}
    1. Chuchalin AG, Novikov K, Avdeev SN, Belevskiĭ AS. Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract. Antibiotiki I Khimioterapiia 1997;42(6):34-8. - PubMed
Cometta 1994 {published data only}
    1. Cometta A, Baumgartner JD, Lew D, Zimmerli W, Pittet D, Chopart P, et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrobial Agents and Chemotherapy 1994;38(6):1309-13. - PMC - PubMed
Dickstein 2016 {published data only}
    1. Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, et al. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol. BMJ Open 2016;6(4):e009956. - PMC - PubMed
Fatehi 2019 {published data only}
    1. Fatehi S, Eshaghi H, Sharifzadeh M, Mirrahimi B, Qorbani M, Tanzifi P, et al. A randomized clinical trial evaluating the efficacy of colistin loading dose in critically ill children. Journal of Research in Pharmacy Practice 2019;8(4):196-201. - PMC - PubMed
Giamarellos‐Bourboulis 2014 {published data only}
    1. Giamarellos-Bourboulis Evangelos J, Mylona V, Antonopoulou A, Tsangaris I, Koutelidakis I, Marioli A, et al. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. Journal of Antimicrobial Chemotherapy 2014;69(4):1111-8. - PubMed
Grudinina 2002 {published data only}
    1. Grudinina SA, Zubkov MM, Krotova LA, Kurdiukova Iu P, Kutsenko MA, Marinin VF, et al. Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study. Antibiotiki I Khimioterapiia 2002;47(1):12-7. - PubMed
Iakovlev 2000 {published data only}
    1. Iakovlev SV, Dvoretskii LI, Shakhova TV. The clinical efficacy of ticarcillin/clavulanate in severe pneumonia. Antibiotiki I Khimioterapiia 2000;45(3):30-4. - PubMed
Iakovlev 2006 {published data only}
    1. Iakovlev SV, Beloborodov VB, Sidorenko SV, Iakovlev VP, Grigor'ev KB, Eliseeva EV, et al. Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis. Antibiotiki I Khimioterapiia 2006;51(7):15-27. - PubMed
Joshi 1999 {published data only}
    1. Joshi M. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Journal of Antimicrobial Chemotherapy 1999;43(3):389-97. - PubMed
Kollef 2012 {published data only}
    1. Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, et al. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Critical Care 2012;16(6):R218. - PMC - PubMed
Lacy 2015 {published data only}
    1. Lacy MK, Stryjewski ME, Wang W, Hardin TC, Nogid B, Luke DR, et al. Telavancin hospital-acquired pneumonia trials: impact of gram-negative infections and inadequate gram-negative coverage on clinical efficacy and all-cause mortality. Clinical Infectious Diseases 2015;Suppl 61:87-93. [DOI: 10.1093/cid/civ536] - DOI - PubMed
Mohamed 2018 {published data only}
    1. Mohamed SS, Dayem AM, Sakr ML, Dwedar IA. The effect of administration of fosfomycin in the management of ventilator-associated pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis 2018;67(3):318.
Muscedere 2012 {published data only}
    1. Muscedere JG, Shorr AF, Jiang X, Day A, Heyland DK. The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. Journal of Critical Care 2012;27(3):322.e7-e14. - PubMed
Nassar 2018 {published data only}
    1. Nassar YS, Saber-Ayad M, Shash RY. Combined microbiological and clinical outcomes of short-term inhaled colistin adjunctive therapy in ventilator-associated pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis 2018;67(4):376-83.
Norrby 1993 {published data only}
    1. Norrby SR, Finch Roger G, Glauser M. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. Journal of Antimicrobial Chemotherapy 1993;31(6):927-37. - PubMed
Patel 2015 {published data only}
    1. Patel AB, Bang A, Singh M, Chelliah LR, Malik A, Khadse S, et al. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 – 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study. BMC Pediatrics 2015;15:186. - PMC - PubMed
Rodloff 1996 {published data only}
    1. Rodloff A, Laubenthal HJ, Bastian A, Bestehorn K, Büchele G, Gaus W. Comparative study of the cost/effectiveness ratio of an initial therapy with imipenem/cilastatin in nosocomial pneumonia [Vergleichende untersuchung zum kosten-/effektivitäts-verhältnis einer initialen therapie mit imipenem/cilastatin bei der nosokomialen pneumonie]. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 1996;31(3):172-80. - PubMed
Straneo 1990 {published data only}
    1. Straneo G, Scarpazza G. Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia. Journal of International Medical Research 1990;18(2):164-70. - PubMed
Tucker 2017 {published data only}
    1. Tucker H, Wible M, Gandhi A, Quintana A. Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials. Infection and Drug Resistance 2017;10:401-17. - PMC - PubMed

References to ongoing studies

Shahrin 2020 {published data only}
    1. Shahrin L, Chisti Mohammod J, Shahid AS, Rahman AS, Islam MZ, Afroze F, et al. Injectable amoxicillin versus injectable ampicillin plus gentamicin in the treatment of severe pneumonia in children aged 2 to 59 months: protocol for an open-label randomized controlled trial. JMIR Research Protocols 2020;9(11):e17735. - PMC - PubMed

Additional references

Aelami 2014
    1. Aelami MH, Lotfi M, Zingg W. Ventilator-associated pneumonia in neonates, infants and children. Antimicrobial Resistance and Infection Control 2014;3(1):30.
Allan 1985
    1. Allan JD, Moellering RC. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. Review of Infectious Diseases 1985;7(Suppl 4):559-71. - PubMed
Alvares 2019
    1. Alvares PA, Arnoni MV, da Silva CB, Safadi MAP, Mimica MJ. Hospital-acquired infections in children: a Latin American tertiary teaching hospital 5-year experience. Pediatric Infectious Disease Journal 2019;38(1):e12. - PubMed
Apisarnthanarak 2003
    1. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003;112(6 Pt 1):1283-9. - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
Bérdy 2005
    1. Bérdy J. Bioactive microbial metabolites. Journal of Antibiotics 2005;58(1):1-26. - PubMed
Bigham 2009
    1. Bigham MT, Amato R, Bondurrant P, Fridriksson J, Krawczeski CD, Raake J, et al. Ventilator-associated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution. Journal of Pediatrics 2009;154(4):582-7. - PubMed
Brok 2008
    1. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. - PubMed
Brok 2009
    1. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive. Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98. - PubMed
Castellini 2018
    1. Castellini G, Bruschettini M, Gianola S, Gluud C, Moja L. Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis. Systematic Reviews 2018;7(1):110. - PMC - PubMed
Cernada 2013
    1. Cernada M, Aguar M, Brugada M, Gutiérrez A, López JL, Castell M, et al. Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatric Critical Care Medicine 2013;14(1):55-61. - PubMed
Chang 2016
    1. Chang I, Schibler A. Ventilator associated pneumonia in children. Paediatric Respiratory Reviews 2016;20:10-6. - PubMed
Chow 2017
    1. Chow EJ, Mermel LA. Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients. Open Forum Infectious Diseases 2017;4(1):ofx006. - PMC - PubMed
CTU 2011
    1. CTU. TSA - Trial Sequential Analysis. www.ctu.dk/tsa/ (accessed 3 April 2020).
Cutler 2017
    1. Cutler GJ, Kharbanda AB, Nowak J, Ortega HW. Injury region and risk of hospital-acquired pneumonia among pediatric trauma patients. Hospital Pediatrics 2017;7(3):164. - PubMed
Davis 2012
    1. Davis J, Finley E. The breadth of hospital-acquired pneumonia: nonventilated versus ventilated patients in Pennsylvania. Pennsylvania Patient Safety Advisory 2012;9(3):99-105.
DeMets 1987
    1. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50. - PubMed
de Neef 2019
    1. Neef M, Bakker L, Dijkstra S, Raymakers-Janssen P, Vileito A, Ista E. Effectiveness of a ventilator care bundle to prevent ventilator-associated pneumonia at the PICU: a systematic review and meta-analysis. Pediatric Critical Care Medicine 2019;20(5):474-80. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. - PubMed
Deville 2003
    1. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatric Infectious Disease Journal 2003;22(Suppl 9):158-63. - PubMed
Eccles 2014
    1. Eccles S, Pincus C, Higgins B, Woodhead M, Guideline Development Group. Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance. BMJ (Clinical Research Ed.) 2014;349:g6722. - PubMed
Ewig 1999
    1. Ewig S, Torres A, El-Ebiary M, Fabregas N, Hernandez C, Gonzalez J, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 1999;159(1):188-98. [PMID: ] - PubMed
Fabregas 1999
    1. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, La Bellacasa JP, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54(10):867-73. [PMID: ] - PMC - PubMed
Fernandez 2011
    1. Fernandez E, Perez R, Hernandez AH, Pilar T, Arteta MA, Ramos JT. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics 2011;3(1):53-72. - PMC - PubMed
Ferrer 2019
    1. Ferrer M, Sequeira T, Cilloniz C, Dominedo C, Bassi GL, Martin-Loeches I, et al. Ventilator-associated pneumonia and PaO2/FIO2 diagnostic accuracy: changing the paradigm? Journal of Clinical Medicine 2019;8(8):1-13. - PMC - PubMed
Fisher 1922
    1. Fisher RA. On the interpretation of χ2 from contingency tables, and the calculation of P. Journal of the Royal Statistical Society 1922;85(1):87-94.
Gartlehner 2019
    1. Gartlehner G, Nussbaumer-Streit B, Wagner G, Patel S, Swinson-Evans T, Dobrescu A, et al. Increased risks for random errors are common in outcomes graded as high certainty of evidence. Journal of Clinical Epidemiology 2019;106:50-9. - PubMed
Giuliano 2018
    1. Giuliano KK, Baker D, Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. American Journal of Infection Control 2018;46(3):322-7. - PubMed
GRADEpro GDT [Computer program]
    1. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed 23 January 2021. Hamilton (ON): McMaster University (developed by Evidence Prime), 2021. Available from gradepro.org.
Gunalan 2021
    1. Gunalan A, Sistla S, Sastry AS, Venkateswaran R. Concordance between the National Healthcare Safety Network (NHSN) Surveillance Criteria and Clinical Pulmonary Infection Score (CPIS) Criteria for Diagnosis of Ventilator-associated Pneumonia (VAP). Indian Journal of Critical Care Medicine 2021;25(3):296-8. - PMC - PubMed
Guyatt 2008
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.) 2008;336(7650):924-6. - PMC - PubMed
Guyatt 2011a
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence - indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. - PubMed
Guyatt 2011b
    1. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2. - PubMed
Guyatt 2011c
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. - PubMed
Higgins 2002
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [DOI: 10.1002/sim.1186] [PMID: ] - DOI - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.
Higgins 2017
    1. Higgins JP, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.
Higgins 2021
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook. - PMC - PubMed
Hróbjartsson 2012
    1. Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ (Clinical Research Ed.) 2012;344:1119. - PubMed
Hróbjartsson 2013
    1. Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):201-11. - PMC - PubMed
Hróbjartsson 2014
    1. Hróbjartsson A, Emanuelsson F, Skou Thomsen AS, Hilden J, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. International Journal of Epidemiology 2014;43(4):1272-83. - PMC - PubMed
ICH‐GCP 2016
    1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Good Clinical Practice (GCP) Guideline Integrated Addendum E6(R2); November 2016. ich.org/page/efficacy-guidelines (accessed prior to 21 October 2021).
Iosifidis 2018
    1. Iosifidis E, Pitsava G, Roilides E. Ventilator-associated pneumonia in neonates and children: a systematic analysis of diagnostic methods and prevention. Future Microbiology 2018;13:1431-46. - PubMed
Jain 2015
    1. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. New England Medical Journal 2015;372(9):835-45. - PMC - PubMed
Jakobsen 2014
    1. Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology 2014;14:120. [PMID: ] - PMC - PubMed
Jarvis 1991
    1. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. American Journal of Medicine 1991;91(3B):185-91. - PubMed
Jones 2010
    1. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America 2010;51(Suppl 1):81-7. - PubMed
Joram 2012
    1. Joram N, Saint Blanquat L, Stamm D, Launay E, Gras-Le Guen C. Healthcare-associated infection prevention in pediatric intensive care units: a review. European Journal of Clinical Microbiology & Infectious Diseases: official publication of the European Society of Clinical Microbiology 2012;31(10):2481-90. - PubMed
Kalil 2016
    1. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America 2016;63(5):61-111. - PMC - PubMed
Kaplan 2003
    1. Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatric Infectious Disease Journal 2003;22(8):677-86. - PubMed
Kelly 2019
    1. Kelly DN, Martin-Loeches I. Comparing current US and European guidelines for nosocomial pneumonia. Current Opinion in Pulmonary Medicine 2019;25(3):263-70. - PubMed
Korang 2019
    1. Korang SK, Safi S, Gluud C, Lausten-Thomsen U, Jakobsen JC. Antibiotic regimens for neonatal sepsis - a protocol for a systematic review with meta-analysis. Systematic Reviews 2019;8(1):306. - PMC - PubMed
Korang 2020
    1. Korang SK, Juul S, Nielsen EE, Feinberg J, Siddiqui F, Ong G, et al. Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project). Systematic Reviews 2020;9(1):262. - PMC - PubMed
Korang 2021b
    1. Korang SK, Safi S, Nava C, Gupta M, Gordon A, Greisen G, et al. Antibiotic regimens for early-onset neonatal sepsis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No: CD013837. [DOI: 10.1002/14651858.CD013837.pub2] - DOI - PMC - PubMed
Korang 2021c
    1. Korang SK, Safi S, Nava C, Greisen G, Gupta M, Lausten-Thomsen U, et al. Antibiotic regimens for late-onset neonatal sepsis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No: CD013836. [DOI: 10.1002/14651858.CD013836.pub2] - DOI - PMC - PubMed
Langer 1987
    1. Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G. Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Medicine 1987;13(5):342-6. - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.
Li 2019
    1. Li K, Li X, Si W, Cui Y, Xia H, Sun X, et al. Preoperative and operation-related risk factors for postoperative nosocomial infections in pediatric patients: a retrospective cohort study. PLOS ONE 2019;14(12):e0225607. - PMC - PubMed
Liu 2013
    1. Liu B, Li SQ, Zhang SM, Xu P, Zhang X, Zhang YH, et al. Risk factors of ventilator-associated pneumonia in pediatric intensive care unit: a systematic review and meta-analysis. Journal of Thoracic Disease 2013;5(4):525-53. - PMC - PubMed
Magill 2013
    1. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, et al. Developing a new, national approach to surveillance for ventilator-associated events. Critical Care Medicine 2013;41(11):2467–75. - PMC - PubMed
Martin‐Loeches 2018
    1. Martin-Loeches I, Rodriguez AH, Torres A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe. Current Opinion in Critical Care 2018;24(5):347-52. - PubMed
Meissner 2003
    1. Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, et al. Hematologic effects of linezolid in young children. Pediatric Infectious Disease Journal 2003;22(Suppl 9):186-92. - PubMed
Milatovic 1987
    1. Milatovic D, Braveny I. Development of resistance during antibiotic therapy. European Journal of Clinical Microbiology 1987;6(3):234-44. - PubMed
Mills 2013
    1. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ (Clinical Research Ed.) 2013;346:f2914. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. BMJ 2009;339:2535. - PMC - PubMed
Mourani 2017
    1. Mourani PM, Sontag MK. Ventilator-associated pneumonia in critically ill children: a new paradigm. Pediatric Clinics of North America 2017;64(5):1039-56. - PubMed
Moustgaard 2020
    1. Moustgaard H, Clayton GL, Jones HE, Boutron I, Jorgensen L, Laursen DR, et al. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study. BMJ (Clinical Research Ed.) 2020;368:l6802. - PMC - PubMed
NICE 2019
    1. National Institute for Health and Care Excellence. Pneumonia (hospital-acquired): antimicrobial prescribing guideline. www.nice.org.uk/guidance/ng139 (accessed prior to 21 October 2021).
Nikolakopoulou 2020
    1. Nikolakopoulou A, Higgins JP, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLOS Medicine 2020;17(4):e1003082. - PMC - PubMed
Papakonstantinou 2020
    1. Papakonstantinou T, Nikolakopoulou A, Higgins JP, Egger M, Salanti G. CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Systematic Reviews - Wiley Online Library 2020;16(1):e1080. - PMC - PubMed
Patel 2000
    1. Patel JC, Mollitt DL, Pieper P, Tepas JJ. Nosocomial pneumonia in the pediatric trauma patient: a single center's experience. Critical Care Medicine 2000;28(10):3530-3. - PubMed
Pogue 1997
    1. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Controlled Clinical Trials 1997;18(6):580-93; discussion 661-6. [PMID: ] - PubMed
Polin 2012
    1. Polin RA, Denson S, Brady MT, Committee on Fetus and Newborn, Committee on Infectious Diseases. Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics 2012;129(4):e1104-9. - PubMed
Pories 1991
    1. Pories SE, Gamelli RL, Mead PB, Goodwin G, Harris F, Vacek P. The epidemiologic features of nosocomial infections in patients with trauma. Archives of Surgery 1991;126(1):97-9. - PubMed
Räcker 2015
    1. Räcker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Medical Research Methodology 2015;15:58. - PMC - PubMed
Review Manager 2020 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.
Richards 1999
    1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999;103(4):e39. - PubMed
Safdar 2005
    1. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respiratory Care 2005;50(6):725-39; discussion 739-41. - PubMed
Saiman 2003
    1. Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, et al. Safety and tolerability of linezolid in children. Pediatric Infectious Disease Journal 2003;22(Suppl 9):193-200. - PubMed
Salanti 2011
    1. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of Clinical Epidemiology 2011;64(2):163-71. - PubMed
Savovic 2018
    1. Savovic J, Turner RM, Mawdsley D, Jones HE, Beynon R, Higgins JP, et al. Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study. American Journal of Epidemiology 2018;187(5):1113-22. - PMC - PubMed
Schünemann 2003
    1. Schünemann HJ, Best D, Vist G, Oxman AD, GRADE Working Group. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Canadian Medical Association Journal 2003;169(7):677-80. - PMC - PubMed
Shein 2019
    1. Shein SL, Karam O, Beardsley A, Karsies T, Prentice E, Tarquinio KM, et al. Development of an antibiotic guideline for children with suspected ventilator-associated infections. Pediatric Critical Care Medicine 2019;20(8):697-706. - PubMed
Shim 2017
    1. Shim S, Yoon BH, Shin IS, Bae JM. Network meta-analysis: application and practice using Stata. Epidemiology and Health 2017;39:e2017047. - PMC - PubMed
Shorr 2017
    1. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respiratory Medicine 2017;122:86-90. - PMC - PubMed
Sopena 2014
    1. Sopena N, Heras E, Casas I, Bechini J, Guasch I, Pedro-Botet ML, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: case-control study. American Journal of Infection Control 2014;42(1):38-42. - PubMed
Srinivasan 2009
    1. Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR. A prospective study of ventilator-associated pneumonia in children. Pediatrics 2009;123(4):1108-15. - PubMed
Stata 2019 [Computer program]
    1. Stata. Version 16. College Station, TX, USA: StataCorp, 2019. Available at www.stata.com.
Stein 1994
    1. Stein F, Trevino R. Nosocomial infections in the pediatric intensive care unit. Pediatric Clinics of North America 1994;41(6):1245-57. - PubMed
Stephenson 2005
    1. Stephenson T. How children's responses to drugs differ from adults. British Journal of Clinical Pharmacology 2005;59(6):670-3. - PMC - PubMed
Su 2020
    1. Su LH, Chen IL, Tang YF, Lee JS, Liu JW. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: a propensity-matched case-control study. PLOS ONE 2020;15(5):e0233265. - PMC - PubMed
Tan 2014
    1. Tan B, Zhang F, Zhang X, Huang YL, Gao YS, Liu X, et al. Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: a meta-analysis of observational studies. European Journal of Pediatrics 2014;173(4):427-34. - PubMed
Thorlund 2009
    1. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? International Journal of Epidemiology 2009;38(1):276-86. - PubMed
Thorlund 2011
    1. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). ctu.dk/tsa/files/tsa_manual.pdf (accessed 3 June 2019).
Torres 2017
    1. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). European Respiratory Journal 2017;50(3):1-26. - PubMed
Turner 2013
    1. Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLOS ONE 2013;8(3):e59202. [PMID: ] - PMC - PubMed
van der Zwet 2005
    1. Zwet WC, Kaiser AM, Elburg RM, Berkhof J, Fetter WP, Parlevliet GA, et al. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates. Journal of Hospital Infection 2005;61(4):300-11. - PubMed
Veroniki 2016
    1. Veroniki A, Straus SE, Fyraridis A, Tricco AC. The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes. Journal of Clinical Epidemiology 2016;76:193-9. - PubMed
Vijay 2018
    1. Vijay G, Mandal A, Sankar J, Kapil A, Lodha R, Kabra SK. Ventilator associated pneumonia in pediatric intensive care unit: incidence, risk factors and etiological agents. Indian Journal of Pediatrics 2018;85(10):861-6. - PMC - PubMed
Wang 2010
    1. Wang P, Dong L, Zhang L, Xia L. Etiology and epidemic characteristics of hospital acquired pneumonia in children. Zhonghua Er Ke za Zhi [Chinese Journal of Pediatrics] 2010;48(6):465-8. - PubMed
Weiner‐Lastinger 2020
    1. Weiner-Lastinger LM, Abner S, Benin AL, Edwards JR, Kallen AJ, Karlsson M, et al. Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017. Infection Control and Hospital Epidemiology 2020;41(1):19-30. [PMID: ] - PMC - PubMed
Weiss 2020
    1. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatric Critical Care Medicine 2020;21(2):e52-106. [PMID: ] - PubMed
Wetterslev 2009
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. - PMC - PubMed
Wetterslev 2017
    1. Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology 2017;17(1):39. [PMID: ] - PMC - PubMed
White 2015
    1. White IR. Network meta-analysis. Stata Journal 2015;15(4):951–85.
World Bank 2020
    1. World Bank. World Bank country and lending groups. datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-coun... (accessed 14 May 2020).
Zingg 2017
    1. Zingg W, Hopkins S, Gayet-Ageron A, Holmes A, Sharland M, Suetens C, et al. Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infectious Diseases 2017;17(4):381-9. - PubMed
Zinna 2016
    1. Zinna SZ, Lakshmanan A, Tan S, McClaughry R, Clarkson M, Soo S, et al. Outcomes of nosocomial viral respiratory infections in high-risk neonates. Pediatrics 2016;138(5):e20161675. - PubMed

References to other published versions of this review

Korang 2021a
    1. Korang SK, Nava C, Nygaard U, Jakobsen JC. Antibiotics for hospital-acquired pneumonia in neonates and children. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No: CD013864. [DOI: 10.1002/14651858.CD013864] - DOI - PMC - PubMed

Publication types